SOTERA HEALTH COMPANY Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SOTERA HEALTH COMPANY (SHC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.05 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- SOTERA HEALTH COMPANY antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 5.05M shares, a 28.24% decline year-over-year.
- SOTERA HEALTH COMPANY antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.82M shares, a 17.36% decline year-over-year.
- SOTERA HEALTH COMPANY antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 5.54M shares, a 3.18% decline year-over-year.
- SOTERA HEALTH COMPANY antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 7.04M shares, a 7.09% decline year-over-year.
- SOTERA HEALTH COMPANY antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 5.56M shares, a 1.02% increase from fiscal 2024.
- SOTERA HEALTH COMPANY antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.50M shares, a 25.10% increase from fiscal 2023.
- SOTERA HEALTH COMPANY antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.40M shares, a 47.98% decline from fiscal 2022.
- SOTERA HEALTH COMPANY antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 8.46M shares, a 251.35% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 5.05M shares 10-Q · filed 2026-08-06 | 4.93M shares 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 4.82M shares 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | 5.56M shares 10-K · filed 2026-02-24 | |||
| 2025-09-30 | 5.54M shares 10-Q · filed 2025-11-04 | 6.08M shares 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | 7.04M shares 10-Q · filed 2026-08-06 | 11.44M shares 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 5.83M shares 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | 5.50M shares 10-K · filed 2026-02-24 | |||
| 2024-09-30 | 5.73M shares 10-Q · filed 2025-11-04 | 5.88M shares 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | 7.58M shares 10-Q · filed 2025-08-08 | 6.83M shares 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | 4.87M shares 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | 4.40M shares 10-K · filed 2026-02-24 | |||
| 2023-09-30 | 10.32M shares 10-Q · filed 2024-11-05 | 4.35M shares 10-Q · filed 2024-11-05 | ||
| 2023-06-30 | 5.59M shares 10-Q · filed 2024-08-05 | 5.07M shares 10-Q · filed 2024-08-05 | ||
| 2023-03-31 | 4.06M shares 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | 8.46M shares 10-K · filed 2025-02-27 | |||
| 2022-09-30 | 4.65M shares 10-Q · filed 2023-11-01 | 3.43M shares 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | 3.79M shares 10-Q · filed 2023-08-03 | 3.35M shares 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | 3.06M shares 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | 2.41M shares 10-K · filed 2024-02-27 | |||
| 2021-09-30 | 2.41M shares 10-Q · filed 2022-11-02 | 2.41M shares 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | 2.41M shares 10-Q · filed 2022-08-04 | 2.41M shares 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | 2.40M shares 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | 2.97M shares 10-K · filed 2023-02-28 | |||
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-11-10 | 0.00 shares 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | 0.00 shares 10-Q · filed 2021-08-12 | 0.00 shares 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | 0.00 shares 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |